You are here

8th Nasopharyngeal Carcinoma Research Day
Date: 
27 Mar 2019
Time: 
8:30am - 5:00pm
Location: 
NIH Complex, Ministry of Health Malaysia
Organized by: 
Nasopharyngeal Carcinoma Society of Malaysia & IMR

Image result for nasopharyngeal carcinoma society of malaysia

The Nasopharyngeal Carcinoma Society of Malaysia (NPCSM) is delighted to announce its
8TH Nasopharyngeal Carcinoma Research day which will be held in National Institute of
Health, Setia Alam, Malaysia. This one-day symposium will be held on the 27th of March
2019.
 
Nasopharyngeal carcinoma or better known as NPC is common cancer with a high incidence
rate in Southern Asia including Malaysia especially among Chinese and Borneo natives.
This annual NPC research day organized by the NPC society is a niche symposium focusing
on NPC research in Malaysia. The event includes a virtual conference in which
renowned international researchers will talk about NPC and external audience
from various locations could participate.

 

PROGRAMME

TIME

AGENDA

0830

Registration and breakfast

0930

Welcome address and talk: NPC as a major cancer in South East Asia - Dr. Alan Khoo, Institute for Medical Research, National Institutes of Health, Ministry of Health Malaysia, and Chairperson Organizing Committee, NPC Research Day

1000

Development of a Specific Inhibitor to Treat Epstein-Barr Virus-Associated Nasopharyngeal Carcinoma - Dr Troy Messick, Wistar Institute, Philadelphia, PA, United States (virtual)

1030

Tea Break and visit to booths

1100 

Epidemiology of NPC - incidence, genetic and non-genetic susceptibility - Dr. Jajah Fachiroh, Faculty of Medicine Universitas Gadjah Mada (UGM), Yogyakarta Indonesia (virtual)

1130 

Establishment of EBV Infection : Role in Pathogenesis of NPC - A. Prof. Dr. Yap Lee Fah, Faculty of Dentistry, University of Malaya, Malaysia

1200

NPC Society of Malaysia Annual General Meeting / visit to booths for non-members

1315

Lunch (Kafetaria Sihat NIH) and visit to booths

1430 The Oral and Nasopharyngeal microbiome in head and neck cancer - Dr. Justine Debelius, Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden (virtual)
1500 Infection and immune control of oncogenic human gamma-herpesviruses- Prof. Christian Munz, Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland (virtual)
1530 Tea Break and visit to booths
1600 Plenary Lecture: The future of NPC research: opportunities and challenges - Prof. Lawrence S. Young, Warwick Cancer Research Centre, University of Warwick, Warwick, United Kingdom (virtual)
1645 Closing
1700 End

 KINDLY CLICK HERE FOR FULL EVENT DETAILS